Global Sleep Apnea Devices Market to Surpass USD 15 Billion by 2032 | DelveInsight
Author : John snow | Published On : 15 Mar 2026
The sleep apnea devices market is fueled by the surging incidence of obstructive sleep apnea (OSA) and associated risks, alongside expanding public health efforts, awareness drives, device design innovations, and robust R&D by leading manufacturers.
New York, USA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The global sleep apnea devices market is expected to surpass USD 15 billion by 2032, according to a new report by DelveInsight. The market is propelled by the rising prevalence of obstructive sleep apnea (OSA) and related risk factors, along with increasing public health initiatives, awareness campaigns, technological advancements in device design, and continued innovation from leading industry players.
DelveInsight’s Sleep Apnea Devices Market Insights report provides comprehensive current and forecasted market data, along with detailed analysis of market shares of leading companies, key drivers, barriers, trends, challenges, and profiles of major players operating in the sleep apnea devices market.
The sleep apnea devices market was valued at USD 9.5 billion in 2024 and is projected to reach USD 15.8 billion by 2032, growing at a CAGR of approximately 6% from 2025 to 2032. North America accounted for the largest regional share of the market in 2024, contributing more than 45% of the total revenue, while positive airway pressure (PAP) devices represented the dominant product segment.
The growth of the market is largely attributed to the increasing prevalence of sleep apnea globally, particularly obstructive sleep apnea, which is strongly associated with rising obesity rates, sedentary lifestyles, and aging populations. In addition, improvements in diagnostic capabilities, increasing awareness about sleep disorders, and growing availability of sleep clinics and home-based diagnostic solutions are supporting market expansion.
Technological innovation remains a central factor shaping the industry. Manufacturers are increasingly focusing on enhancing patient comfort, portability, and usability of devices while integrating digital monitoring and connectivity features. Continuous advancements in CPAP, BiPAP, and APAP systems are enabling more personalized and convenient therapy, contributing to greater adoption rates. The shift toward home-based treatment solutions is also accelerating market growth as patients increasingly prefer convenient and cost-effective at-home management of sleep apnea.
Other important growth factors include rising comorbid conditions such as hypertension, diabetes, and cardiovascular disease, which are closely linked to untreated sleep apnea. Expanding reimbursement coverage in several healthcare systems and growing healthcare infrastructure are further encouraging diagnosis and treatment adoption worldwide.
Regionally, North America continues to dominate the sleep apnea devices market due to a high prevalence of sleep disorders, strong awareness among patients and healthcare providers, and the presence of major medical device manufacturers. The region also benefits from supportive reimbursement policies, extensive sleep clinic networks, and ongoing product innovation.
Europe represents another significant market, supported by robust healthcare infrastructure, growing diagnosis rates, and increasing prevalence of obesity and age-related sleep disorders. Expansion of sleep laboratories and home diagnostic technologies is also contributing to steady market growth across the region.
Meanwhile, the Asia-Pacific region is witnessing rapid growth due to increasing awareness of sleep disorders, rising healthcare investments, and a growing patient population affected by obesity and lifestyle-related health issues. Expanding access to diagnostic services and treatment devices across emerging economies is expected to further accelerate regional market expansion.
Recent industry developments highlight the pace of innovation across the sector. In December 2025, SleepRes, Inc. received FDA 510(k) clearance for its Kricket PAP device incorporating KPAP™ technology for obstructive sleep apnea patients weighing over 66 pounds, designed for both home and hospital environments. In October 2025, Good Sleep Co.’s Hushd Pro Z-Link received FDA clearance as a mandibular advancement device for treating snoring and mild-to-moderate obstructive sleep apnea. In June 2025, Samsung’s Galaxy Watch Sleep Apnea detection feature received CE marking for distribution across 34 European markets as well as Australia and Singapore. In May 2025, Zynex submitted a 510(k) application to the FDA for its NiCO™ noninvasive CO-oximeter, while Wesper received FDA clearance for a cannula-free home sleep test device. Earlier in February 2025, Huxley Medical’s SANSA home sleep test obtained regulatory approval for cellular data upload functionality, Viatom received FDA clearance for its O2Ring pulse oximeter, and PranaQ’s TipTraQ AI-powered wearable device was also cleared. In January 2025, ResMed expanded its footprint in Asia by launching the AirSense 11 CPAP device in India.
Key companies operating in the sleep apnea devices market include Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd., Vivos Therapeutics, Inc., Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics GmbH, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., BPL Medical Technologies, Elmaslar Medikal A.S., BMC, and several other emerging and established manufacturers.
To read more about the latest highlights related to the sleep apnea devices market, get a snapshot of the key highlights @ https://www.delveinsight.com/report-store/sleep-apnea-devices-market?utm_source=apac&utm_medium=promotion&utm_campaign=akpr
Sleep apnea devices are medical technologies used to diagnose, monitor, and treat sleep apnea, a condition characterized by repeated pauses in breathing during sleep. These devices help maintain open airways through systems such as continuous positive airway pressure (CPAP), bilevel positive airway pressure (BiPAP), and automatic positive airway pressure (APAP) machines that deliver pressurized air during sleep. Additional treatment options include oral appliances and adaptive servo-ventilation systems for complex cases, while diagnostic technologies such as polysomnography and wearable monitoring systems support accurate detection and disease management. By improving breathing during sleep, these devices help enhance sleep quality, reduce daytime fatigue, and lower the risk of serious complications such as cardiovascular disease.
Related report
Sleep Apnea - Epidemiology Forecast - 2034
DelveInsight’s “Sleep Apnea – Epidemiology Forecast – 2034” report delivers an in-depth understanding of sleep apnea historical and forecasted epidemiology in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. Several prominent companies are actively operating in the sleep apnea devices market, including Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd., Vivos Therapeutics, Inc., Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics GmbH, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., BPL Medical Technologies, Elmaslar Medikal A.Ş., BMC, among others.
Sleep Apnea - Pipeline Insight, 2026
DelveInsight’s, “Sleep Apnea - Pipeline Insight, 2026” report provides comprehensive insights about 10+ companies and 14+ pipeline drugs in Sleep Apnea pipeline landscape. Several prominent companies are actively operating in the sleep apnea devices market, including Koninklijke Philips N.V., ResMed, Fisher & Paykel Healthcare Limited, AMBULANCE (SHENZHEN) TECH. CO. LTD, BMC, Beijing Aeonmed Co., Ltd., Hebei Topson Medical Technology Co., Ltd., Hunan VentMed Medical Technology Co., Ltd., Vivos Therapeutics, Inc., Guangdong Pigeon Medical Apparatus Co., Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, SOMNOmedics GmbH, VYAIRE, Compumedics Limited, Drive DeVilbiss International, Nox Medical, eXciteOSA Inc., BPL Medical Technologies, Elmaslar Medikal A.Ş., BMC, among others.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Abhishek kumar
Email: [email protected]
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
